133 related articles for article (PubMed ID: 33353255)
1. Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein-Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation.
Lees A; Barr JF; Gebretnsae S
Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33353255
[TBL] [Abstract][Full Text] [Related]
2. Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP).
Lees A; Zhou J
J Vis Exp; 2021 Jun; (172):. PubMed ID: 34180904
[TBL] [Abstract][Full Text] [Related]
3. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides.
Shafer DE; Toll B; Schuman RF; Nelson BL; Mond JJ; Lees A
Vaccine; 2000 Jan; 18(13):1273-81. PubMed ID: 10649629
[TBL] [Abstract][Full Text] [Related]
4. Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents.
Lees A; Nelson BL; Mond JJ
Vaccine; 1996 Feb; 14(3):190-8. PubMed ID: 8920699
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP).
J Vis Exp; 2021 Jul; (173):. PubMed ID: 34241598
[TBL] [Abstract][Full Text] [Related]
6. O-phthalaldehyde based quantification of polysaccharide modification in conjugate vaccines.
Rajendar B; Reddy MVNJ; Suresh CNV; Rao GS; Matur RV
J Pharm Biomed Anal; 2024 Apr; 241():115995. PubMed ID: 38309096
[TBL] [Abstract][Full Text] [Related]
7. Optimization and applications of CDAP labeling for the assignment of cysteines.
Pipes GD; Kosky AA; Abel J; Zhang Y; Treuheit MJ; Kleemann GR
Pharm Res; 2005 Jul; 22(7):1059-68. PubMed ID: 16028006
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans mannan-protein conjugate as vaccine candidate.
Bystrický S; Paulovicová E; Machová E
Immunol Lett; 2003 Feb; 85(3):251-5. PubMed ID: 12663139
[TBL] [Abstract][Full Text] [Related]
9. Improved conjugation and purification strategies for the preparation of protein-polysaccharide conjugates.
Suárez N; Massaldi H; Franco Fraguas L; Ferreira F
J Chromatogr A; 2008 Dec; 1213(2):169-75. PubMed ID: 18992885
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of yeast mannans with protein employing cyanopyridinium agent (CDAP)--an effective route of antifungal vaccine preparation.
Bystrický S; Machová E; Bartek P; Kolarova N; Kogan G
Glycoconj J; 2000 Oct; 17(10):677-80. PubMed ID: 11425187
[TBL] [Abstract][Full Text] [Related]
11. Activation of cellulose membranes with 1,1'-carbonyldiimidazole or 1-cyano-4-dimethylaminopyridinium tetrafluoroborate as a basis for the development of immunosensors.
Stöllner D; Scheller FW; Warsinke A
Anal Biochem; 2002 May; 304(2):157-65. PubMed ID: 12009691
[TBL] [Abstract][Full Text] [Related]
12. Universal method for protein bioconjugation with nanocellulose scaffolds for increased cell adhesion.
Kuzmenko V; Sämfors S; Hägg D; Gatenholm P
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4599-607. PubMed ID: 24094166
[TBL] [Abstract][Full Text] [Related]
13. Preparation, optimization and application of affinity absorbent with a polysaccharide YCP as the ligand.
Ding R; Zhou Y; Zhang X; Zhu R; Yao WB; Gao XD
Carbohydr Polym; 2014 Apr; 104():73-9. PubMed ID: 24607162
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin.
Kossaczka Z; Szu SC
Glycoconj J; 2000 Jun; 17(6):425-33. PubMed ID: 11294508
[TBL] [Abstract][Full Text] [Related]
15. Conjugate chemistry and cellular processing of EGF-dextran.
Carlsson J; Blomquist E; Gedda L; Liljegren A; Malmström PU; Sjöström A; Sundin A; Westlin JE; Zhao Q; Tolmachev V; Lundqvist H
Acta Oncol; 1999; 38(3):313-21. PubMed ID: 10380822
[TBL] [Abstract][Full Text] [Related]
16. Binding of glycosaminoglycans to cyano-activated agarose membranes: kinetic and diffusional effects on yield and homogeneity.
Mattern KJ; Deen WM
Carbohydr Res; 2007 Nov; 342(15):2192-201. PubMed ID: 17610855
[TBL] [Abstract][Full Text] [Related]
17. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.
Beuvery EC; Speijers GJ; Lutz BI; Freudenthal D; Kanhai V; Haagmans B; Derks HJ
Dev Biol Stand; 1986; 63():117-28. PubMed ID: 3091432
[TBL] [Abstract][Full Text] [Related]
18. Preparative purification of soybean agglutinin by affinity chromatography and its immobilization for polysaccharide isolation.
Franco-Fraguas L; Plá A; Ferreira F; Massaldi H; Suárez N; Batista-Viera F
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 790(1-2):365-72. PubMed ID: 12767345
[TBL] [Abstract][Full Text] [Related]
19. A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components.
Gao F; Lockyer K; Burkin K; Crane DT; Bolgiano B
Hum Vaccin Immunother; 2014; 10(9):2744-53. PubMed ID: 25483488
[TBL] [Abstract][Full Text] [Related]
20. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells.
Andersson A; Holmberg A; Carlsson J; Carlsson J; Pontén J; Westermark B
Int J Cancer; 1991 Feb; 47(3):439-44. PubMed ID: 1704355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
